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Abstract
Background: Dendritic cells (DC) have been proposed to facilitate sexual transmission of HIV-1
by capture of the virus in the mucosa and subsequent transmission to CD4+ T cells. Several T cell
subsets can be identified in humans: naïve T cells (TN) that initiate an immune response to new
antigens, and memory T cells that respond to previously encountered pathogens. The memory T
cell pool comprises central memory (TCM) and effector memory cells (TEM), which are
characterized by distinct homing and effector functions. The TEM cell subset, which can be further
divided into effector Th1 and Th2 cells, has been shown to be the prime target for viral replication
after HIV-1 infection, and is abundantly present in mucosal tissues.
Results:  We determined the susceptibility of TN, TCM and TEM cells to DC-mediated HIV-1
transmission and found that co-receptor expression on the respective T cell subsets is a decisive
factor for transmission. Accordingly, CCR5-using (R5) HIV-1 was most efficiently transmitted to
TEM cells, and CXCR4-using (X4) HIV-1 was preferentially transmitted to TN cells.
Conclusion: The highly efficient R5 transfer to TEM cells suggests that mucosal T cells are an
important target for DC-mediated transmission. This may contribute to the initial burst of virus
replication that is observed in these cells. TN cells, which are the prime target for DC-mediated X4
virus transmission in our study, are considered to inefficiently support HIV-1 replication. Our
results thus indicate that DC may play a decisive role in the susceptibility of TN cells to X4 tropic
HIV-1.
Background
Several CD4+ T cell subsets can be identified in humans:
naïve T cells (TN) to mount an immune response to a vari-
ety of new antigens, and memory T cells to respond to pre-
viously encountered pathogens. TN  cells preferentially
circulate between blood and secondary lymphoid tissues,
using high endothelial venules to enter lymph nodes [1].
The memory T cell pool comprises distinct populations of
central memory (TCM) and effector memory T cells (TEM),
characterized by distinct homing and effector function
[2,3]. Like TN cells, TCM cells express CCR7 and CD62L,
two receptors required for migration to T cell areas of sec-
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ondary lymphoid tissue. They furthermore have limited
effector function, but can proliferate and become TEM cells
upon secondary stimulation with antigen, and therefore
play a role in long term protection. TEM cells have lost
CCR7 expression, and home to peripheral tissues and sites
of inflammation to provide immediate protection against
pathogens [2,3]. Consequently, TN and TCM cells are pri-
marily found in blood and lymphoid tissue, whereas TEM
cells are enriched in gut, liver and lung. Within the TEM cell
subset, effector Th1 and Th2 cells are recognized, which
are classified by different functional properties based on
unique cytokine profiles. Th1 cells produce high levels of
IFNγ and TNFβ, which is instrumental in cell-mediated
immunity against intracellular pathogens like viruses. Th2
cells secrete a large variety of cytokines (IL-4, IL-5, IL-9
and IL-13) that are crucial for the clearance of parasites,
like helminths. Both types of effector cells play a role in
the induction of a humoral (antibody) response against
different extracellular pathogens [4].
Sexual transmission of HIV-1 involves the crossing of
mucosal tissue by the virus, and several studies have
shown that one of the very first cell types encountered are
intraepithelial and submucosal dendritic cells (DC). Con-
sequently, they have been proposed to facilitate HIV-1
transmission and infection [5-8]. DC are professional
antigen presenting cells that sample the environment at
sites of pathogen entry. Sentinel immature DC (iDC)
develop into mature effector DC (mDC) upon activation
by microorganisms or inflammatory signals, and migrate
to the draining lymph nodes where they encounter and
stimulate naïve Th cells [9,10]. DC are able to capture
HIV-1 by a range of receptors, of which the best studied
example is DC-SIGN [11]. Subsequent transmission to T
cells takes place in lymph nodes via cell-cell contact
through an 'infectious synapse' [12]. Additionally, DC can
support local virus replication in T cells present in the
mucosal tissue [7,8].
An increasing number of studies on HIV-1 and SIV dem-
onstrate that the initial burst of viral replication takes
place in CCR5+ CD4+ (effector) memory T cells in the lam-
ina propria of mucosal tissues [13-18]. CCR5 and CXCR4
are the major co-receptors used by HIV-1, with CCR5
being the initial co-receptor used by the virus after trans-
mission. This receptor is primarily expressed on the mem-
ory T cell subset and macrophages [19]. Over time, HIV-1
starts to use CXCR4 in some patients, thereby expanding
its target cell repertoire to TN cells, coinciding with faster
disease progression [20,21].
Because DC play an important role in HIV-1 pathogene-
sis, and TN, TCM and TEM cells have distinct functions and
locations in the body, we set out to investigate the contri-
bution of DC in infection of these T cell subsets. We found
that CCR5-using (R5) HIV-1 is efficiently transmitted to
TEM cells but not to TN cells. Transmission to TCM cells was
of intermediate efficiency. Transmission to pure popula-
tions of Th1 or Th2 cells, or to an unbiased population
containing both types (Th0) was equally efficient. The
highly efficient R5 transfer to TEM  cells suggests that
mucosal (TEM) cells are an important target for DC-medi-
ated transmission, which may contribute to the observed
initial burst of virus replication in these cells. CXCR4-
using (X4) HIV-1 could be transmitted to all T cell subsets,
due to expression of CXCR4 on all subsets. Surprisingly,
X4 HIV-1 was preferentially transmitted to TN cells, which
are considered to inefficiently replicate X4 HIV-1 [22-24].
This study shows that co-receptor expression is a decisive
factor for DC-mediated HIV-1 transmission, and more
importantly, that DC may play a crucial role in making TN
cells susceptible to X4 HIV-1 replication later in infection.
Results
T cell subsets differ in susceptibility to DC-mediated 
transmission of R5 and X4 HIV-1
To investigate whether different CD4+ T cell subsets differ
in their susceptibility to DC-mediated HIV-1 transmis-
sion, we isolated by live sorting highly purified popula-
tions of CD45RA+  CD45RO-  naïve T cells (TN) and
CD45RA- CD45RO+ memory T cells from pure CD4+ T
cells. Based on the expression of CCR7, a homing receptor
for secondary lymphoid tissue, the memory pool was fur-
ther divided in CCR7+ central memory T cells (TCM) and
CCR7- effector memory T cells (TEM) [2,3]. We subse-
quently incubated DC with the R5 virus JR-CSF isolate or
the X4 virus LAI isolate for 2 hr, followed by washing steps
to remove unbound virus. After addition of the respective
T cell subsets, we determined the transmission efficiency
by measuring the accumulation of HIV-1 capsid protein
p24 (CA-p24) in T cells by FACS. To prevent subsequent
rounds of HIV-1 replication after transmission in this sin-
gle-cycle transmission assay, we added an inhibitor of the
viral protease (saquinavir, [25,26]).
In a control experiment without HIV-1, no CA-p24 posi-
tive CD3+ T cells were scored (Fig. 1A). Addition of R5
HIV-1 resulted in high percentages of CA-p24+ TEM cells,
and hardly any CA-p24+ TN cells (2.9 and 0.1 %, respec-
tively). The transmission to TCM cells was of intermediate
efficiency (1.9%). With X4 HIV-1, the pattern was
reversed: X4 HIV-1 was preferentially transmitted to TN
cells (4%), then to TCM cells (2.2%), and the transmission
to TEM cells was least efficient (1.4%) (Fig. 1A). Overall, X4
transmission was more efficient than R5 transmission,
and could take place to all subsets. For both viruses, the
percentage CA-p24+ T cells reached a maximum value 2
days post transmission, and these data are quantified in
Fig. 1B. This experiment demonstrates that there is not
one exclusive T cell subset that is the preferred target ofRetrovirology 2006, 3:52 http://www.retrovirology.com/content/3/1/52
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DC-mediated HIV-1 transmission, but that the efficiency
depends on the tropism of the transmitted virus.
DC-mediated HIV-1 transmission is co-receptor dependent
The different transmission patterns for R5 and X4 HIV-1
prompted us to investigate the co-receptor expression on
each T cell subset (Fig. 2A). We found that the level of co-
receptor expression for both CCR5 and CXCR4 correlates
with the transmission efficiencies depicted in Fig. 1B:
CCR5 expression is most pronounced on TEM cells, and is
undetectable on TN cells; CXCR4 is detectable on all sub-
sets, but its expression declines from TN cells via TCM to
TEM cells.
To investigate the role of co-receptor expression in DC-
mediated HIV-1 transmission, we added the well-
described inhibitors RANTES and AMD3100 in the single-
cycle transmission assay. These compounds inhibit HIV-1
infection of T cells by blocking the co-receptors CCR5 and
CXCR4, respectively [27,28]. Transmission of HIV-1 was
completely blocked through the addition of these com-
DC-mediated HIV-1 transmission is co-receptor dependent Figure 2
DC-mediated HIV-1 transmission is co-receptor 
dependent. (A) FACS analysis of TN, TCM and TEM cells for 
CD4 and co-receptors CCR5 and CXCR4. Open histograms 
represent isotype controls. (B) Transmission inhibition by 
co-receptor ligands and a fusion inhibitor. A single-cycle 
transmission assay to TN, TCM and TEM cells was performed 
with R5 and X4 HIV-1 loaded DC. Prior to co-culture with 
DC, the T cells were pre-incubated with ligands for CCR5 
(RANTES) or CXCR4 (AMD3100) (grey bars) or alterna-
tively, with fusion inhibitor T1249 (black bars). After 2 days, 
the percentage CA-p24+ T cells was determined by FACS. 
The percentage inhibition of transmission relative to trans-
mission without inhibitors is indicated on the y-axis. Error 
bars represent standard deviations.
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T cell subsets differ in susceptibility to DC-mediated trans- mission of R5 and X4 HIV-1 Figure 1
T cell subsets differ in susceptibility to DC-mediated 
transmission of R5 and X4 HIV-1. (A) DC were incu-
bated with R5 or X4 HIV-1, or mock treated, followed by 
extensive washing to remove unbound virus. DC were sub-
sequently co-cultured with CD4+ naïve T cells (TN), central 
memory T cells (TCM) or effector memory T cells (TEM) in 
the presence of saquinavir to prevent spreading infection 
(single-cycle transmission assay). Two days after transmis-
sion, T cells were harvested and stained for CD3 and intrac-
ellular CA-p24 to determine the percentage HIV+ T cells. 
Representative FACS plots are shown. (B) Summary of one 
representative experiment. Error bars represent standard 
deviations. * p < 0.05 ; ** p < 0.01; *** p < 0.001.
no virus               R5  HIV-1           X4 HIV-1
TN
TCM
TEM
CD3 CD3 CD3
CD3 CD3 CD3
CD3 CD3 CD3
C
A
-
p
2
4
C
A
-
p
2
4
C
A
-
p
2
4
C
A
-
p
2
4
C
A
-
p
2
4
C
A
-
p
2
4
C
A
-
p
2
4
C
A
-
p
2
4
C
A
-
p
2
4
A
B
0
1
2
3
4
5
TN TCM TEM
R5 HIV-1
%
 
C
A
-
p
2
4
+
 
T
 
c
e
l
l
s
TN TCM TEM
X4 HIV-1
***
*
**
*
***
*Retrovirology 2006, 3:52 http://www.retrovirology.com/content/3/1/52
Page 4 of 10
(page number not for citation purposes)
pounds (Fig. 2B, grey bars). We furthermore could block
transmission completely with inhibitor T1249 (Fig. 2B,
black bars). This peptide prevents fusion of viral and cel-
lular membranes [29]. Our results thus demonstrate that
DC-mediated HIV-1 transmission requires 'regular' infec-
tion through CD4 and a co-receptor.
Method of T cell stimulation determines HIV-1 
susceptibility
In addition to quantification of the transmission effi-
ciency in a single-cycle transmission assay (Fig. 1 and 2),
we followed viral replication after transmission (Fig. 3). In
this spreading infection assay, we did not add saquinavir
to allow cell-cell spread of newly produced virus. Replica-
tion of R5 and X4 HIV-1 in TN, TCM and TEM cells following
DC-mediated transmission reflects the results of the sin-
gle-cycle transmission assay: R5 HIV-1 preferentially rep-
licates in memory T cells, whereas X4 HIV-1 prefers TN
cells over the memory subsets (Fig. 3A and 3B).
Since this spreading infection assay involves two different
steps,  i.e. transmission and subsequent replication, we
also studied R5 and X4 HIV-1 replication in TN, TCM and
TEM cells in a DC-independent system. Therefore, cellular
Spreading infection assay Figure 3
Spreading infection assay. Replication of R5 (A) and X4 (B) virus in TN, TCM and TEM cells after DC-mediated HIV-1 trans-
mission. Alternatively, the T cell subsets were stimulated by crosslinking CD3/CD28 with antibodies and infected with R5 (C) 
or X4 (D) virus. Viral replication was followed by CA-p24 ELISA on the supernatant. Error bars represent standard deviations.
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proliferation was induced by cross linking of CD3 and
CD28 on the T cells with antibodies (Fig. 3C and 3D). As
expected, the susceptibility of all T cell subsets to R5 HIV-
1 replication was low after CD3/CD28 stimulation. This
phenomenon was previously described for CD4+ T cells in
general, and is the consequence of CCR5 down regulation
and production of natural CCR5 ligands that compete for
co-receptor binding [30,31]. But despite this low replica-
tion capacity, the pattern of R5 replication was compara-
ble to the replication after DC-mediated transmission of
R5 HIV-1: replication was lower in TN cells. Surprisingly,
X4 replication in TN cells was significantly delayed in com-
parison to TCM and TEM cells, which does not reflect the
enhanced transmission and replication in TN cells in the
transmission experiments (Fig. 1 and 3B).
This discrepancy prompted us to compare HIV-1 replica-
tion in T cells stimulated by either DC or α-CD3/CD28
antibodies, without any complicating factors like trans-
mission steps. We therefore stimulated all T cell subsets
with DC, or alternatively, with α-CD3/CD28 antibodies
and harvested the T cells after 4 days of proliferation. The
cells were subsequently infected with X4 HIV-1. DC-stim-
ulated TN cells were more susceptible to X4 HIV-1 replica-
tion than the memory subsets (Fig. 4A), which reflects the
replication after transmission (Fig. 3B). The reverse was
observed with α-CD3/CD28 stimulated T cells (Fig. 4A),
which is in concordance with the results of Fig. 3D in
which the cells were infected immediately after stimula-
tion. This indicates that the enhanced replication of X4
HIV-1 in TN cells following DC-mediated transmission, is
due to a higher HIV-1 susceptibility. It further demon-
strates that crosslinking of CD3 and CD28 by antibodies
is not comparable to DC-T cell stimulation, although this
crosslinking is considered to mimic DC encounter. The
difference between both stimulation methods is further
manifested by the proliferative capacity of the T cells, as
determined by 3H-thymidine incorporation (Fig 4B). The
proliferation pattern of the different T cell subsets after
DC or α-CD3/CD28 stimulation is clearly not the same.
DC transmit HIV-1 with equal efficiency to Th1 and Th2 
cells, or to an unpolarized population
The TEM cell subset can be further divided into effector Th1
and Th2 cells [4]. We generated in vitro polarized popula-
tions of pure Th1 and Th2 cells, or an unbiased popula-
tion containing both types (Th0 cells), by culturing
purified TN cells with or without IL-12 or IL-4, as previ-
ously described [32]. We next investigated whether HIV-1
is differently transmitted to these subsets of effector Th1,
Th2 or Th0 cells. In addition, we tested different mature
DC subsets. Depending on the type of pathogen and tis-
sue factors, immature DC develop into mature effector
DC that are specialized to stimulate naïve T cells to
develop into IFNγ-producing Th1 cells or IL-4-producing
Th2 cells, designated DC1 and DC2 respectively [33].
DC0 induce an unpolarized response (Th0). DC0, DC1
and DC2 were generated by culturing immature DC with
maturation factors (MF, IL-1β and TNFα) only (DC0), or
MF with either IFNγ (DC1) or prostaglandin E2 (DC2)
[34].
The intracellular cytokine profiles of the effector Th cell
populations were analyzed by FACS (Fig 5A). The Th1
population consists primarily of IFNγ producers, whereas
the Th2 population contains mostly IL-4 producers. The
unpolarized Th0 population is composed of both cell
types. All T cell subsets expressed similar levels of CCR5
and CXCR4, and proliferated to a comparable extent, as
determined by 3H incorporation (results not shown).
Method of T cell stimulation determines HIV-1 susceptibility Figure 4
Method of T cell stimulation determines HIV-1 sus-
ceptibility. (A) Comparison of viral replication in TN, TCM 
and TEM cells that were stimulated by DC or by CD3/CD28 
crosslinking with antibodies. The T cells were stimulated for 
4 days, harvested and re-plated before infection with X4 
HIV-1. Viral spread was followed by CA-p24 ELISA, of which 
the results of day 6 are shown. (B) To measure T cell prolif-
eration TN, TCM or TEM cells were incubated with DC or α-
CD3/CD28 antibodies and after 4 days, cellular proliferation 
was determined by 3H-thymidine incorporation. Error bars 
represent standard deviations. * p < 0.05 ; ** p < 0.01; *** p 
< 0.001.
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DC0, DC1 and DC2 were subsequently incubated with R5
and X4 HIV-1, followed by washing and addition of Th0,
Th1 and Th2 cells. Two days later, the transmission effi-
ciency was determined in the single-cycle transmission
assay (Fig. 5B). Consistent with Fig. 1B, R5 virus was a bit
more efficiently transmitted to these polarized TEM cells
than X4 HIV-1. More importantly, we found no signifi-
cant differences in HIV-1 transmission efficiency to Th0,
Th1 or Th2 cells within one DC subset, i.e. a particular DC
subset transmits HIV-1 with equal efficiency to Th0, Th1
or Th2 cells. We also did not find a preference of HIV-1
transmission by a DC subset and its corresponding Th
type: DC1 was the most efficient HIV-1 transmitter in all
cases. The latter was previously demonstrated by us, using
unpolarized peripheral blood leukocytes (PBL) and T cell
lines [35]. We now show that this also applies to polarized
Th subsets.
Discussion
TN, TCM and TEM cells have distinct functions and locations
in the body [1,2], which may have, combined with the dif-
ferential expression of HIV-1 co-receptors, an impact on
HIV-1 transmission and infection. Since DC play an
important role in HIV-1 pathogenesis, we studied the DC-
mediated transmission of R5 and X4 virus to the different
T cell subsets. Although we used only two (well-
described) strains of HIV-1, our results suggest that in gen-
eral R5 HIV-1 is preferentially transmitted to TEM cells,
whereas DC transmit X4 HIV-1 most efficiently to the TN
subset.
It is known that R5 viruses are primarily transmitted
between individuals and that X4 viruses emerge only later
in infection [19,36]. An increasing number of studies on
HIV-1 and SIV demonstrate that the initial burst of viral
replication takes place in CCR5+ CD4+ (effector) memory
T cells in the lamina propria of the mucosa [13-18]. Later
in infection, proviral DNA can be isolated from both
naïve and memory CD4+ T cells [37,38]. The mechanism
responsible for R5 predominance early in infection is not
known. One proposed mechanism is the exclusive trans-
port of R5 viruses over the epithelial barrier by epithelial
CCR5+ cells [39]. Moreover, DC were proposed to be
responsible due to the preferential replication of R5 HIV-
1 [40-42], although this R5 replication is not entirely
exclusive [43-46]. In addition, DC do not need to be pro-
ductively infected to transmit HIV-1 to T cells [47,48], and
DC can transmit both X4 as R5 HIV-1 to T cells [42]. In
fact, we demonstrate in this study that X4 virus is generally
transmitted more efficiently than R5 virus. Therefore, DC
are probably not the 'gatekeepers' that select R5 viruses,
although their role in sexual transmission is a crucial one
[7,8].
One of the remaining questions is whether DC either
facilitate local HIV-1 replication, or transport the virus to
the lymph nodes, or both [7,8,19]. R5 HIV-1 is efficiently
transmitted to TCM cells (Fig. 1), which are primarily
present in lymphoid tissue, and even more efficiently to
TEM cells, which are abundantly present at sites of viral
entry in the mucosa. This suggests that transmission can
take place at both locations.
Although X4 HIV-1 is very efficiently transmitted to TN
cells, X4 virus does not emerge in recently infected HIV
patients. Thus, DC-mediated X4 HIV-1 transmission to T
cells may not take place following sexual transmission, or
may not be a factor of relevance. DC may nonetheless play
an important role later in infection (when X4 HIV
DC transmit HIV-1 with equal efficiency to Th0, Th1 and Th2  cells Figure 5
DC transmit HIV-1 with equal efficiency to Th0, Th1 
and Th2 cells. (A) In vitro generated polarized populations 
of Th1 and Th2 cells, or an unbiased population (Th0), were 
analyzed for intracellular cytokines IFNγ and IL-4 by FACS. 
The percentage single and double positive cells is indicated. 
(B) Th0, Th1 and Th2 cells were co-cultured with R5 or X4 
virus-loaded DC in a single-cycle transmission assay to deter-
mine the transmission efficiency. Different DC subsets were 
used: DC1 that stimulate TN cells to develop into Th1 cells, 
DC2 that induce Th2 cells, or DC0 that induce an unpolar-
ized response (Th0). The percentage CA-p24+ T cells was 
determined by FACS 2 days post transmission. Error bars 
represent standard deviations. * p < 0.05 ; ** p < 0.01; *** p 
< 0.001.
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emerges), e.g. by making TN cells susceptible to X4 HIV-1
as we have shown in this study.
We furthermore subdivided TEM cells into Th1 and Th2
cells, which did not reveal more differences. DC transmit
HIV-1 with equal efficiency to Th1 or Th2 cells, or to an
unbiased population containing both types (Th0).
Reports on the ability of R5 and X4 virus to replicate in
Th0, Th1 or Th2 cells are not univocal [49-52]. Based on
our results, the type of TEM cell (Th0, 1 or 2) is not of
importance for susceptibility to DC-mediated HIV-1
transmission, although the state of activation is an impor-
tant (though not decisive) factor [53-55]. Furthermore,
antigen specific T cells may be preferred [56].
We have shown here that the decisive factor for efficient
HIV-1 transmission to the different T cell subsets is co-
receptor expression. These HIV-1 transmission results
with DC are in concordance with other studies that have
shown in vivo and ex vivo the correlation between differen-
tial expression of CCR5 and CXCR4 on naïve and memory
T cells and HIV-1 susceptibility [57-59]. We are the first to
further divide the memory T cell pool into populations of
effector and central memory T cells. We furthermore
found that the presence of DC seems to enhance HIV-1
infection and replication, but does not change the pattern
of susceptibility. Under certain conditions, no correlation
was found between co-receptor expression and HIV-1 sus-
ceptibility. When the T cells were stimulated with α-CD3/
CD28 antibodies, replication of X4 HIV-1 in TN cells was
restricted in comparison to the memory subsets. We there-
fore compared stimulation of T cells by α-CD3/CD28
with stimulation by DC, and found differences in T cell
proliferation and X4 susceptibility.
Crosslinking CD3 and CD28 by antibodies is a com-
monly used laboratory method for T cell stimulation, and
mimics T cell activation through triggering of these mole-
cules by DC-bound MHC-II and CD80/86, respectively.
However, many more interactions play a role in DC-T cell
interaction and stimulation, e.g. CD30L-CD30; OX40L-
OX40; 41BBL-41BB; CD70-CD27; ICOSL-ICOS; CD40-
CD40L and ICAM-1-LFA-1 [10,33,60,61]. Each of these
interactions could have an influence on the replication
capacity of HIV-1 in T cells, and some of these interactions
therefore are the subject of further study. Our results dem-
onstrate that DC play a vital role in priming TN cells to
become susceptible to HIV-1, and that α-CD3/CD28 stim-
ulation is not a very good model for DC stimulation in the
context of HIV-1 studies.
Conclusion
We have shown that DC transmit R5 and X4 HIV-1 with
different efficiencies to TN, TCM and TEM cells, and that this
correlates with co-receptor expression of the different T
cell subsets. The highly efficient transmission of R5 HIV-1
to TEM cells, which are abundantly present at sites of viral
entry, may contribute to the observed burst of viral repli-
cation in these cells after HIV-1 infection. Later on in
infection, DC may play an important role in the replica-
tion of X4 HIV-1 in TN cells.
Materials and methods
Generation of monocyte-derived dendritic cells
Peripheral blood mononuclear cells (PBMC) were iso-
lated by density centrifugation on Lymphoprep
(Nycomed, Torshov, Norway). Subsequently, PBMC were
layered on a Percoll gradient (Pharmacia, Uppsala, Swe-
den) with three density layers (1.076, 1.059, and 1.045 g/
ml). The light fraction with predominantly monocytes
was collected, washed, and seeded in 24-well culture
plates (Costar, Cambridge, MA, USA) at a density of 5 ×
105 cells per well. After 60 min at 37°C, non-adherent
cells were removed, and adherent cells were cultured to
obtain immature DC in Iscove's modified Dulbecco's
medium (IMDM; Life Technologies Ltd., Paisley, United
Kingdom) with gentamicin (86 μg/ml; Duchefa, Haarlem,
The Netherlands) and 10% fetal calf serum (HyClone,
Logan, UT, USA), supplemented with GM-CSF (500 U/
ml; Schering-Plough, Uden, The Netherlands) and IL-4
(250 U/ml; Strathmann Biotec AG, Hannover, Germany).
At day 3, the culture medium with supplements was
refreshed. At day 6, maturation was induced by culturing
the DC with maturation factors only (MF; IL-1β (10 ng/
ml) and TNFα(50 ng/ml); Strathmann Biotec AG), or MF
with either IFNγ (1000 U/ml; Strathmann Biotec AG), or
prostaglandin E2 (10-6 M; Sigma-Aldrich, St. Louis, MO),
see results for more details [34]. After two days, mature
CD14- CD1b+ CD83+ DC were obtained. All subsequent
tests were performed after harvesting and extensive wash-
ing of the cells to remove all factors. Mature DC were ana-
lysed for the expression of cell surface molecules on a
FACScan (BD Biosciences, San Jose, CA, USA). Mouse
anti-human mAbs were used against the following mole-
cules: CD14 (BD Biosciences), CD1b (Diaclone,
Besançon, France), CD83 (Immunotech, Marseille,
France) and ICAM-1 (CD54) (Pelicluster, Sanquin,
Amsterdam, The Netherlands). All mAb incubations were
followed by incubation with FITC-conjugated goat F(ab')2
anti-mouse IgG and IgM (Jackson ImmunoResearch Lab-
oratories, West Grove, PA, USA).
CD4+ T cells
Naïve and memory T cells were live sorted from pure
CD4+ T cells on a FACS ARIA (BD Biosciences). The fol-
lowing mouse-anti-human antibodies were used:
CD45RA-FITC (Coulter, Hialeah, FL, USA), CD45RO-
APC (BD Biosciences), CD4-PE-Cy7 (BD Biosciences).
Rat-anti-human CCR7 (BD Biosciences) incubation was
followed by biotin-rabbit-anti-rat (Zymed LaboratoriesRetrovirology 2006, 3:52 http://www.retrovirology.com/content/3/1/52
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Inc., San Francisco, CA, USA) and streptavidin-PerCp-
Cy5.5 (BD Biosciences) incubation. CD4+  CD45RA+
CD45R0- cells were considered naïve T cells (TN). CD4+
CD45RA- CD45R0+ cells (the memory population) was
separated into central memory (TCM) (CCR7+) and effec-
tor memory (TEM) (CCR7-) cells, according to the classifi-
cation described by Sallusto et al [2]. Polarized Th1 and
Th2 cells, and an unpolarized population containing both
types (Th0 cells) were generated from purified TN cells as
previously described [32]. In short, TN cells (105/200 μl)
were stimulated with immobilized α-CD3 (CLB-T3/3; 1
μg/ml) and α-CD28 (CLB-CD28/1; 2 μg/ml) (both from
Sanquin, Amsterdam, The Netherlands) and cultured for
10 days in the absence (Th0) or presence of IL-12 (100 U/
ml; a gift from Dr. M. K. Gately, Hoffma-La Roche) or IL-
4 (1000 U/ml) for Th1 and Th2 cells respectively. To gen-
erate fully polarized Th cells, the cells were restimulated
with PHA (10 μg/ml; Difco, Detroit, MI, USA) and 3000
rad-irradiated feeder cells (PBMC of two unrelated donors
and EBV-B cells (JY cells)) in the presence of IL-4 for Th0
cells; IL-4 neutralizing antibodies (CLB_IL-4/6, Sanquin)
plus IL-12 for Th1 cells; and IL-12 neutralizing antibodies
(U-CyTech, Utrecht, the Netherlands) plus IL-4 for Th2
cells. All T cells were cultured in IMDM with 10% FCS,
gentamycin and IL-2 (Cetus, Emeryville, CA, USA). Dur-
ing co-culture with DC, Staphylococcus enterotoxin B (SEB;
Sigma-Aldrich; final concentration, 10 pg/ml) was added.
α-CD3/CD28 stimulation of T cells for viral replication
experiments was done with mouse mAb to human CD28
(CLB-CD28/1) and human CD3 (CLB-T3/4E-1XE, San-
quin).
Cytokine production by polarized Th cells
12 days after the second stimulation round, resting T cells
were restimulated with PMA (10 ng/ml) and ionomycin
(1 μg/ml) for 6 hr, the last 4.5 hr in the presence of Brefel-
din A (10 μg/ml) (all Sigma-Aldrich). Cells were fixed in
2% PFA, permeabilized with 0.5% saponin (Sigma-
Aldrich), and stained with anti-IFNγ -FITC and anti-IL4-
PE (both BD Biosciences). Cells were then analysed by
FACS.
Virus stocks
C33A cervix carcinoma cells were transfected using cal-
cium phosphate with 5 μg of the molecular clone of
CXCR4-using HIV-1 LAI or CCR5-using HIV-1 JR-CSF. The
virus containing supernatant was harvested 3 days post
transfection, filtered and stored at -80°C. The concentra-
tion of virus was determined by CA-p24 ELISA. C33A cells
were maintained in Dulbecco's Modified Eagle's Medium
(DMEM) (Invitrogen, Breda, the Netherlands), supple-
mented with 10% FCS, 2 mM sodium pyruvate, 10 mM
HEPES, 2 mM L-glutamine, penicillin (100 U/ml) (Sigma-
Aldrich) and streptomycin (100 μg/ml; Invitrogen).
HIV transmission assay and CA-p24 measurement
Fully matured DC (IFNγ/MF if indicated otherwise) were
incubated in a 96-well-plate (45 × 103 DC/100 μl/well)
with HIV-1 (15 ng CA-p24/well) for 2 hr at 37°C. The DC
were washed with PBS after centrifugation at 400 × g to
remove unbound virus. Washing was repeated 2 times,
followed by addition of 50 × 103 TN, TCM or TEM cells. In
some experiments, T1249 (250 ng/ml; Trimeris, Durham,
NC, USA), RANTES (500 ng/ml, R&D Systems, Abingdon,
UK) or AM3100 (10 μg/ml, Sigma-Aldrich) was added.
The latter two were pre-incubated with the T cells for 30
min at 37°C. Prior to addition to DC, the T cells were ana-
lyzed by FACS with the following mouse anti-human anti-
bodies: CD4-PE, CCR5-PE and CXCR4-PE (all BD
Biosciences). Viral replication after transmission was fol-
lowed by measuring CA-p24 in the culture supernatant by
ELISA. To determine intracellular CA-p24 in the single-
cycle transmission assay, saquinavir (Roche, London, UK
at 0.2 μM) was added to prevent cell-to-cell spread of
newly produced virions. After 48 hr, the T cells were har-
vested and stained with FITC-labeled CD3 (BD Bio-
sciences), followed by fixation with 4% PFA and washing
with washing buffer (PBS with 2 mM EDTA and 0.5%
BSA). Fixated cells were then washed with perm/wash
buffer (BD Biosciences), and incubated with PE-labeled
CA-p24 (KC57-RD1, Coulter) followed by washing with
successively perm/wash- and washing buffer. Cells were
then analysed by FACS.
T cell proliferation
Fully matured DC (45 × 103 DC/well) were incubated in a
96-well-plate with TN, TCM, TEM cells, or polarized Th cells
(50 × 103 T cells/well) in a final volume of 200 μl. After 2
days, cell proliferation was assessed by the incorporation
of [3H]-TdR after a pulse with 13 KBq/well during the last
16 hr of the co-culture, as measured by scintillation spec-
troscopy. Alternatively, TN, TCM or TEM cells were stimu-
lated with α-CD3/CD28 antibodies, followed by the [3H]-
TdR pulse 2 days later.
Statistical analysis
Data were analysed for statistical significance (GraphPad
InStat, Inc, San Diego, CA, USA) using ANOVA. A p value
< 0.05 was considered to be significant.
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